Yolandi van Rooyen1, Aletta E Schutte1,2, Hugo W Huisman1, Fritz C Eloff3, Johan L Du Plessis3, Annamarie Kruger4,2, Johannes M van Rooyen5. 1. Hypertension in Africa Research Team (HART), North-West University (Potchefstroom Campus), Private Bag X6001, Potchefstroom, 2520, South Africa. 2. MRC Research Unit for Hypertension and Cardiovascular Disease, North-West University, Potchefstroom, South Africa. 3. Occupational Hygiene and Health Research Initiative (OHHRI), North-West University, Potchefstroom, South Africa. 4. Africa Unit for Transdisciplinary Health Research (AUTHeR), North-West University, Potchefstroom, South Africa. 5. Hypertension in Africa Research Team (HART), North-West University (Potchefstroom Campus), Private Bag X6001, Potchefstroom, 2520, South Africa. johannes.vanrooyen@nwu.ac.za.
Abstract
INTRODUCTION: Reduced lung function is associated with a risk for the development of cardiovascular disease. This association may be due to chronic inflammation which is often present in those with reduced lung function. PURPOSE: We investigated the possible role of systemic inflammation as the mediator between lung function and arterial stiffness in 1534 black South Africans. METHODS: Spirometric data including forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC) were obtained. C-reactive protein (CRP), interleukin-6 (IL-6), blood pressure (BP) and carotid-radial pulse wave velocity (PWV) were determined. RESULTS: In multivariable-adjusted models, an independent inverse association was found between IL-6 and FEV1 (β = -0.20, p < 0.001) and FVC (β = -0.18, p < 0.001). Similar results were found for CRP. PWV was inversely associated with FEV1 (β = -0.06, p = 0.037). No association was found between inflammatory markers, BP or PWV. CONCLUSION: Reduced lung function was associated with increased inflammation and arterial stiffness. The lack of association between arterial stiffness and inflammatory markers suggests that inflammation may not be the mediating link between lung and vascular function in this population.
INTRODUCTION: Reduced lung function is associated with a risk for the development of cardiovascular disease. This association may be due to chronic inflammation which is often present in those with reduced lung function. PURPOSE: We investigated the possible role of systemic inflammation as the mediator between lung function and arterial stiffness in 1534 black South Africans. METHODS: Spirometric data including forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC) were obtained. C-reactive protein (CRP), interleukin-6 (IL-6), blood pressure (BP) and carotid-radial pulse wave velocity (PWV) were determined. RESULTS: In multivariable-adjusted models, an independent inverse association was found between IL-6 and FEV1 (β = -0.20, p < 0.001) and FVC (β = -0.18, p < 0.001). Similar results were found for CRP. PWV was inversely associated with FEV1 (β = -0.06, p = 0.037). No association was found between inflammatory markers, BP or PWV. CONCLUSION: Reduced lung function was associated with increased inflammation and arterial stiffness. The lack of association between arterial stiffness and inflammatory markers suggests that inflammation may not be the mediating link between lung and vascular function in this population.
Authors: Bongani M Mayosi; Alan J Flisher; Umesh G Lalloo; Freddy Sitas; Stephen M Tollman; Debbie Bradshaw Journal: Lancet Date: 2009-08-24 Impact factor: 79.321
Authors: A E Schutte; D van Vuuren; J M van Rooyen; H W Huisman; R Schutte; L Malan; N T Malan Journal: J Hum Hypertens Date: 2006-07-20 Impact factor: 3.012
Authors: N Ahluwalia; L Drouet; J-B Ruidavets; B Perret; J Amar; H Boccalon; H Hanaire-Broutin; J Ferrières Journal: Atherosclerosis Date: 2005-08-29 Impact factor: 5.162
Authors: Zhi-Jie Zheng; Wayne D Rosamond; Lloyd E Chambless; F Javier Nieto; Ralph W Barnes; Richard G Hutchinson; Herman A Tyroler; Gerardo Heiss Journal: Am J Prev Med Date: 2005-12 Impact factor: 5.043
Authors: Emma Barinas-Mitchell; Lewis H Kuller; Kim Sutton-Tyrrell; Refaat Hegazi; Patricia Harper; Juliet Mancino; David E Kelley Journal: Diabetes Care Date: 2006-10 Impact factor: 19.112
Authors: Iftikhar J Kullo; James B Seward; Kent R Bailey; Lawrence F Bielak; Brandon R Grossardt; Patrick F Sheedy; Patricia A Peyser; Stephen T Turner Journal: Am J Hypertens Date: 2005-08 Impact factor: 2.689
Authors: Shuen Yee Lee; Micheál Mac Aogáin; Kai Deng Fam; Kar Ling Chia; Nur A'tikah Binte Mohamed Ali; Margaret M C Yap; Eric P H Yap; Sanjay H Chotirmall; Chin Leong Lim Journal: PLoS One Date: 2019-11-26 Impact factor: 3.240
Authors: Kennedy M Peter; James R Pike; John S Preisser; Anna M Kucharska-Newton; Michelle L Meyer; Maria C Mirabelli; Priya Palta; Timothy Hughes; Kunihiro Matsushita; Yifei Lu; Gerardo Heiss Journal: Angiology Date: 2022-05-27 Impact factor: 3.299
Authors: Kamalita Pertiwi; Leanne K Küpers; Johanna M Geleijnse; Peter L Zock; Anne J Wanders; Herculina S Kruger; Tertia van Zyl; Iolanthé M Kruger; Cornelius M Smuts Journal: Lipids Health Dis Date: 2020-06-16 Impact factor: 3.876
Authors: Joshua A N van Apeldoorn; Eva L van der Linden; Silver Bahendeka; Erik Beune; Karlijn A C Meeks; Kerstin Klipstein-Grobusch; Bert-Jan van den Born; Charles Agyemang Journal: J Hypertens Date: 2022-02-01 Impact factor: 4.844
Authors: Blanche C Ip; Nan Li; Medina Jackson-Browne; Melissa Eliot; Yingying Xu; Aimin Chen; Bruce P Lanphear; Adam J Spanier; Joseph M Braun Journal: J Dev Orig Health Dis Date: 2020-10-27 Impact factor: 2.401